Medicare's new authority to negotiate lower prescription drug prices represents a signature accomplishment of the Biden-Harris administration. Here's what to know as the first set of talks wraps up.

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

Down here in Louisiana, we’ve got enough financial worries, especially after four years of Biden-induced inflation. Yet, ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

Adam Gray (D-CA), and Neal Dunn (R-FL) introduced the Protecting Patient Access to Cancer and Complex Therapies Act. This ...

The House passed the “One Big Beautiful Bill Act” on July 3, which includes sweeping changes to healthcare and some pharma-related provisions.

Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald ...

Mehmet Oz recently took the reins as the new head of the Centers for Medicare & Medicaid Services (CMS), which oversees health coverage for nearly half of Americans. He will be responsible for ...